| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/09/2004 | EP1425390A2 Materials and methods to promote repair of nerve tissue |
| 06/09/2004 | EP1425389A2 Human antibodies specific for interleukin 15 (il-15) |
| 06/09/2004 | EP1425388A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 06/09/2004 | EP1425387A2 Human glucose-dependent insulin-secreting cell line |
| 06/09/2004 | EP1425385A2 Systems and methods for screening pharmaceutical chemicals |
| 06/09/2004 | EP1425382A2 Novel human collagen proteins and polynucleotides encoding the same |
| 06/09/2004 | EP1425380A2 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 06/09/2004 | EP1425379A2 Method and structure for growing living organic tissue |
| 06/09/2004 | EP1425302A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 06/09/2004 | EP1425297A2 Isolation of neural stem cells using gangliosides and other surface markers |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1425045A1 Adenoviral vector and related system and methods of making and use |
| 06/09/2004 | EP1425042A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 06/09/2004 | EP1425039A2 Human papilloma virus immunoreative peptides |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |
| 06/09/2004 | EP1381866B1 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 06/09/2004 | EP1263449A4 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP0914415B1 Method and compositions for obtaining mature dendritic cells |
| 06/09/2004 | EP0906432B1 Recombinant alpha-2,3-sialyltransferases and their uses |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | EP0681608B1 Therapeutic applications of chimeric organogenesis |
| 06/09/2004 | DE10139492B4 Verfahren zur Reparatur einer mutierten RNA aus einer gendefekten DNA und zum gezielten Abtöten von Tumorzellen durch RNA-Transspleißen sowie Verfahren zum Nachweis von natürlich-transgespleißter zellulärer RNA A method of repairing a mutated RNA from a genetically defective DNA and for targeted killing of tumor cells by RNA trans-splicing as well as methods for the detection of naturally-trans-spliced cellular RNA |
| 06/09/2004 | CN1503844A Novel expression vectors |
| 06/09/2004 | CN1503841A genes for s-adenosyl 1-methionine: jasmonic acid carboxyl methyltransferase and a method for a development of pathogen-and stress-resistant plants using the genes |
| 06/09/2004 | CN1503840A Method for in vivo ex vivo and in vitro repair and regeneration of cartrilage and collagen and bone remodeling |
| 06/09/2004 | CN1503678A Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502695A Mouse cholesterol ester synthetase-2 gene promotor |
| 06/09/2004 | CN1502694A Development of clone of domestic animal used as mammary gland boireactor by means of Cre-LoxP site-specific targeting somatic cell |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502691A Establishment identification and use for internal differentiation skin model of multipotential mesenchyme stem cell |
| 06/09/2004 | CN1502630A Monocloned antibody of O6-methylguanine-DNA methyltransferase preparation process and test kit |
| 06/09/2004 | CN1502325A Ascorbic acid aqueous solution and preparation process thereof |
| 06/09/2004 | CN1502227A Method for culturing wheat tissue capable of overcoming gene distrubance |
| 06/09/2004 | CN1153064C Method of enriching rare cells |
| 06/09/2004 | CN1152961C Transcription factor controlling phenylpropanol biosynthesis pathway |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/08/2004 | US6747193 Hybrid maize plant and seed 32H58 |
| 06/08/2004 | US6747136 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
| 06/08/2004 | US6747134 Antibody immunologically reactive with serine protease EOS |
| 06/08/2004 | US6747130 Tenebrio antifreeze proteins |
| 06/08/2004 | US6747036 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 06/08/2004 | US6747010 NKT cell-activating agents containing α-glycosylceramides |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6746871 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746837 Multiple drug resistance gene atrD of aspergillus nidulans |
| 06/08/2004 | US6746697 Composition containing Heliopsis longipes root extract and oral carrier |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/08/2004 | US6746670 Regulatory T cells; methods |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046712A2 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046337A2 Multilayered microcultures |
| 06/03/2004 | WO2004046322A2 Replication of biological tiussue |
| 06/03/2004 | WO2004046320A2 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/03/2004 | WO2004046318A2 Improved clonal cell lines derived from bti-tn-5b1-4 |
| 06/03/2004 | WO2004046312A2 Methods for in vitro expansion of hematopoietic stem cells |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004045548A2 Genetic constructs and compositions comprising rre and cte and uses thereof |
| 06/03/2004 | WO2004045527A2 Modulation of nima-related kinase 6 expression |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004045493A2 Methods of inducing or enhancing cartilage repair |
| 06/03/2004 | WO2004035766A3 In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2003103611A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003100029A3 Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use |
| 06/03/2004 | WO2003100024A3 Treatment for diabetes |
| 06/03/2004 | WO2003092604A3 Vascularization enhanced graft constructs |
| 06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
| 06/03/2004 | WO2003089580A3 Cancer models |
| 06/03/2004 | WO2003089450A3 Fusion polypeptides and methods for inhibiting microbial adhesion |
| 06/03/2004 | WO2003088995A3 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003052056A3 Egviii endoglucanase and nucleic acids encoding the same |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107460 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106896 System and method for forming a non-ablative cardiac conduction block |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106555 Neurogenin3 and production of pancreatic islet cells |
| 06/03/2004 | US20040106551 Human papilloma virus immunoreactive peptides |
| 06/03/2004 | US20040106199 Aqueous solutions comprising monopotassium salt of cyclodextrin-6A-monophosphate, or cyclodextrin derivatives of nitrates, sulfates, and phosphates, for biosynthsis of taxol, tananes; oxidation resistance, sustained release the nutrients |
| 06/03/2004 | US20040106197 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106195 Method for identification of cell growth or differentiation factors |
| 06/03/2004 | US20040106159 Using protein fragments to induce cytokine response in CD8 and/or CD4 lymphocytes; screening mammals for previous exposure to antigens |